Search Results - "Seraphim, A"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling by Faccenda, D, Tan, C H, Seraphim, A, Duchen, M R, Campanella, M

    Published in Cell death and differentiation (01-05-2013)
    “…Mitochondrial structure has a central role both in energy conversion and in the regulation of cell death. We have previously shown that IF 1 protects cells…”
    Get full text
    Journal Article
  2. 2

    Reducing time to angiography and hospital stay for patients with high-risk non-ST-elevation acute coronary syndrome: retrospective analysis of a paramedic-activated direct access pathway by Koganti, S, Patel, N, Seraphim, A, Kotecha, T, Whitbread, M, Rakhit, R D

    Published in BMJ open (20-06-2016)
    “…ObjectiveTo assess whether a novel ‘direct access pathway’ (DAP) for the management of high-risk non-ST-elevation acute coronary syndromes (NSTEACS) is safe,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Epileptic spasms without hypsarrhythmia in infancy and childhood: tonic spasms as a seizure type by De Marchi, Luciana R, Seraphim, Evelyn A, Corso, Jeana T, Naves, Pedro VF, de Carvalho, Kelly Cristina, Ramirez, Milton David H, Ferrari-Marinho, Taissa, Guaranha, Mirian SB, Yacubian, Elza Márcia T

    Published in Epileptic disorders (01-06-2015)
    “…Epileptic spasms were defined by the International League Against Epilepsy Task Force on Classification and Terminology in 2001 as a specific seizure type…”
    Get full text
    Journal Article
  7. 7

    Computed tomography vs cardiovascular magnetic resonance imaging derived extracellular volume fraction in patients with stable new-onset chest pain by Saberwal, B, Patel, K, Scully, P R, Klotz, E, Seraphim, A, Augusto, J, Vandermolen, S, Knott, K, Thornton, G D, Haberland, U, Sutcliffe, J, Khanji, M Y, Moon, J C, Treibel, T A, Pugliese, F

    Published in European heart journal (12-10-2021)
    “…Abstract Background Computed tomography (CT) is increasingly recognised as a diagnostic modality across a range of cardiovascular conditions and is now…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage by Bicho Augusto, J.A, Johner, N, Shah, D, Nordin, S, Knott, K, Lau, C, Alfarih, M, Seraphim, A, Vijapurapu, R, Ramaswami, U, Steeds, R, Kozor, R, Hughes, D, Moon, J, Namdar, M

    Published in European heart journal (01-11-2020)
    “…Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native…”
    Get full text
    Journal Article
  10. 10

    Dark blood ischemic LGE segmentation using a deep learning approach by Torlasco, C, Papetti, D, Mene, R, Artico, J, Seraphim, A, Badano, LP, Moon, JC, Parati, G, Xue, H, Kellman, P, Nobile, M

    “…Abstract Funding Acknowledgements Type of funding sources: None. Introduction The extent of ischemic scar detected by Cardiac Magnetic Resonance (CMR) with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Comparison of the prognostic value of stress and rest pulmonary transit time estimation using myocardial perfusion CMR by Seraphim, A, Knott, K, Menacho, K, Augusto, J, Davies, R, Joy, G, Hui, X, Treibel, T, Cooper, J, Petersen, S, Fontana, M, Hughes, A, Moon, J, Manisty, C, Kellman, P

    “…Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): British Heart Foundation Clinical Research Training Fellowship…”
    Get full text
    Journal Article
  13. 13

    Microvascular and mechanical improvements following bariatric surgery in the obese; mechanistic insights from advanced & automated quantitative perfusion cardiac MRI by Joy, G, Crane, JD, Augusto, JB, Lau, C, Seraphim, A, Bhuva, A, Moon, JC, Xue, H, Kellman, P, Cruickshank, JK, Mcgowan, BM, Manisty, C

    “…Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): Guy"s and St Thomas" Charity University College…”
    Get full text
    Journal Article
  14. 14

    Influences on myocardial perfusion in non-obstructive coronary disease: an observational quantitative perfusion mapping study by Knott, K, Seraphim, A, Augusto, JB, Camaioni, C, Kotecha, T, Xue, H, Joy, G, Bhuva, AN, Manisty, C, Brown, LAE, Wong, J, Fontana, M, Kellman, P, Plein, S, Moon, JC

    “…Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): This study was supported by a Clinical…”
    Get full text
    Journal Article
  15. 15

    Proposed stages of Fabry disease: insights from multiparametric cardiac MRI and advanced ECG by Bicho Augusto, JA, Johner, N, Shah, D, Nordin, S, Knott, K, Lau, C, Seraphim, A, Hughes, R, Vijapurapu, R, Bhuva, A, Steeds, RP, Kozor, R, Hughes, D, Moon, JC, Namdar, M

    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Staging of Fabry disease (FD) cardiomyopathy uses multiparametric cardiac MRI…”
    Get full text
    Journal Article
  16. 16

    Use of quantitative myocardial perfusion mapping by CMR for characterisation of ischaemia in patients post coronary artery bypass graft surgery by Seraphim, A, Knott, K, Beirne, AM, Augusto, J, Menacho, K, Joy, G, Artico, J, Bhuva, A, Torii, R, Triebel, T, Xue, H, Moon, J, Jones, D, Kellman, P, Manisty, C

    “…Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): British Heart Foundation Background Quantitative myocardial…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer by Seraphim, L A, Perrapato, S D, Slocum, H K, Rustum, Y M, Huben, R P

    Published in The Journal of urology (01-03-1991)
    “…Several cytotoxic agents have been identified as effective in the treatment of superficial transitional cell carcinoma of the bladder, including doxorubicin,…”
    Get more information
    Journal Article